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Radiofrequency (RF) catheter ablation is currently the treatment 
of choice in patients with accessory pathways (APs) and Wolff–
Parkinson–White syndrome, and is shown to have a success rate 
>95 %.1 APs usually have endocardial ventricular and atrial insertions, 
located close to the atrioventricular valve rings, making most 
endocardial catheter ablation procedures relatively straightforward 
and yielding a high success rate. However, this is not the case when 
the AP distal end is closer to the epicardial surface or its atrial or 
ventricular insertion is located far from the atrioventricular groove, 
and a small subset of patients will fail ablation procedures using a 
conventional endocardial approach.2,3
Endocardial Ablation
Endocardial catheter ablation has limitations, including the inability 
to access intramural or epicardial portions of arrhythmia circuits. 
Epicardial AP location was pointed to as the cause of 8 % of prolonged 
and failed AP ablation attempts.4 Technological improvements, such as 
cooled-tip, larger-tip ablation catheters, contact-force technology and 
different energy sources for tissue ablation have not completely solved 
the problem, and some arrhythmia substrates might not be accessible 
from the endocardium.5
Several other factors may contribute to RF ablation failure: difficulties 
with catheter manipulation, including an inability to reach the 
appropriate AP site, catheter instability (particularly in right-sided 
AP) or inadequate tissue contact; inaccurate mapping related to AP 
slanting and AP localisation away from an endocardial-positioned 
catheter or in the setting of Ebstein’s anomaly; proximity of the AP to 
vital structures, such as a coronary artery or the atrioventricular node; 
associated structural abnormalities, such as congenital venous system 
anomalies or acquired coronary system stenosis that has developed as 
a consequence of previous unsuccessful ablation attempts.4
Some of these difficulties can be overcome during cardiac surgery 
(open-chest surgery or thoracoscopy), an epicardial approach 
performed through epicardial vessels of the coronary sinus (CS) 
system or through percutaneous catheterisation of the pericardial 
space, as described by Sosa et al.5,6
Intravenous Mapping and Ablation
AP located in the posteroseptal and left posterior areas may be 
difficult to ablate due to relative epicardial localisation, thickness of 
the myocardium, anatomic complexity of this area and coexistence 
of a CS diverticulum, containing a pouch and neck.7,8 CS anatomy 
should be carefully assessed, either by venography or CT, to rule 
out diverticulum, which may be present in 15–20  % of refractory 
posteroseptal APs. Cooled-tip catheter ablation inside the CS venous 
system and middle cardiac vein is effective in most epicardial 
posteroseptal APs. However, one has to be aware that a fast 
conducting AP may become a decremental AP after an ablation 
attempt. In this instance, the ECG may change, lacking overt pre-
excitation during sinus rhythm. Its correct identification is possible if 
a thorough programmed electrical stimulation is carried out after the 
ablation attempt.3,4,8,9 
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In 1992 Haïssaguerre et al. reported the effectiveness and safety of 
radiofrequency catheter ablation of left lateral APs via the mid or 
distal CS when endocardial approaches are unsuccessful.10 They had 
no significant complications, except a marked nonspecific pain during 
RF energy application.10 In 1993 Langberg et al. evaluated a group 
of patients with left-sided APs that were difficult to ablate from the 
endocardial surface. It was found that the absence of an AP potential 
during endocardial mapping in combination with a relatively large AP 
potential within the CS may be a useful marker of a subepicardial 
pathway localised in the atrioventricular groove. In this select group 
of patients, radiofrequency application from within the CS appears to 
enhance ablation efficacy.11
Morady et al. reported on a series of difficult catheter ablation cases: 
in three patients who were initially thought to have a right or left 
posteroseptal AP, the effective target site was 2–3  cm within the CS 
or within a posterior interventricular branch of the CS. In two patients 
thought to have a left lateral AP, the AP site was mapped within the CS 
in the region of the lateral mitral annulus. In each of these patients, AP 
potentials were absent or small in amplitude from the endocardium, 
but a relatively large potential was recorded within the CS.4
The CS has a myocardial coat with extensive connections to the left 
and right atria. An extension of this coat through the posterior coronary 
vein, the middle cardiac vein or a diverticulum neck can connect to 
the left ventricular epicardium and form epicardial posteroseptal and 
left posterior AP.1,12 CS APs (defined by earliest activation within the 
venous system) were identified in 36 % of patients with posteroseptal 
or left posterior AP in a study of a select group of patients where most 
had failed previous attempts at ablation; the actual incidence of such 
pathways should be much smaller.12 Usually CS APs have an oblique 
course because of the oblique orientation of the fibres connecting the 
CS myocardial coat with the left atrium.13 CS angiography revealed a CS 
diverticulum in 21 % of patients and fusiform or bulbous enlargement 
of the small cardiac vein, middle cardiac vein or CS in 9 % of patients.12 
These venous anomalies mostly arise 1.5  cm away from the CS 
and before the middle cardiac vein, but they can originate from the 
middle or posterior cardiac veins as well.1 Successful ablation of these 
pathways may be achieved while ablating in the diverticulum neck.1,14
A precise knowledge of the CS anatomy and its potential abnormalities, 
such as the presence of diverticulum or persistent left superior vena 
cava, as well as CS electrogram recordings, are essential for successful 
RF catheter ablation in patients with a prior history of multiple 
ablation failures or in whom successful ablation cannot be achieved.1 
The presence of a negative delta wave in lead II is suggestive of 
an epicardial localisation of the AP (identifying a CS AP), with a 
sensitivity of 70 %.1 Takahashi et al.15 reported that the combination 
of a steep positive delta wave in lead aVR and a deep S wave in lead 
V6 (R wave ≤ S wave) during maximal pre-excitation had the highest 
specificity for identifying epicardial coronary vein posteroseptal APs, 
while the highest sensitivity is provided by a negative delta wave 
in lead II.
Ablation in posteroseptal diverticula has lower success rates and 
is correlated with more procedural complications due to the close 
proximity of the epicardial coronary arteries, risk of venous perforation, 
tamponade, venous occlusion or heart block.1 Success can usually 
be improved by targeting the neck of the diverticulum, applying 
irrigated-tip catheters, using cryoablation or performing the subxiphoid 
epicardial approach.16 Although RF ablation can be done safely inside 
the CS, cryoablation could be a safer alternative, especially if the best 
ablation location is in close proximity to a coronary artery, although a 
higher rate of recurrences have been reported.9,17
An alternate method for mapping right-sided APs that did not stand the 
test of time involved the placement of a multipolar mapping catheter 
within the right coronary artery. In many instances, the right coronary 
artery is located away from the annulus and therefore provides only 
a limited anatomic area for mapping compared with percutaneous 
epicardial mapping. These multipolar 2-F or 3-F mapping catheters are 
no longer available. The rationale for this approach was analogous to 
Table 1: Worldwide Experience of Epicardial Mapping and Ablation
 
Reference N Accessory Pathway Location Anatomic Abnormality Cool-tip Success Results
Sapp et al., 200127 1 Posteroseptal   Coronary sinus diverticulum N N  Surgery
Saad et al., 200216 1 Posteroseptal   N N  Success ENDO guided by  
         epicardium
DePaola et al., 200428 1 Posteroseptal   N Y 
Valderrábano et al.,  7 Right free-wall = 5/   N 2/7  ENDO guided by epicardium= 5 
20046  posteroseptal = 2
Schweikert et al.,  10 RPL = 2/ right free-  RAA–RV diverticulum = 3 8/10 3/10  ENDO guided by epicardium= 2 
20035  wall = 3/left free- 
   wall = 2/LPS = 2/MS = 1
Scanavacca et al.,  21 RPS = 8/RP = 2/ right  Coronary sinus diverticulum = 2 6/21 6/21  ENDO guided by epicardium= 2 
20153  free-wall = 1/RAS = 1/  
   LPS = 1/LP = 1/ left free- 
   wall = 4/PS=3
Faustino et al.,  1 Posteroseptal  RAA–RV diverticulum = 1 Y Y  ENDO after epicardium= 5,  
201629        surgery = 4
Total 42 Posteroseptal = 19,   Coronary sinus diverticulum = 16 %, 15 (36 %) 13 (31 %) 20 (48 %) 
   right free-wall = 9,   RAA–RV diverticulum= 10 %  
   left free-wall = 6,  
   right posterior or  
   posterolateral = 4
Endo = endocardium; LP = left posterior; LPS = left posteroseptal; MS = midseptal; PS = posteroseptal; RAA–RV = right atrial appendage–right ventricle; RAS = right anteroseptal; RP = right 
posteroseptal; RPL = right posterolateral.
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the placement of a multipolar catheter within the CS for mapping left 
free-wall pathways.6
Percutaneous Epicardial Mapping and Ablation
There are some case reports and a few series of cases about using 
the epicardial percutaneous subxiphoid approach to map and ablate 
APs (see Table 1).3
Pericardial Access
Access to the epicardial space was achieved as previously described 
by Sosa et al.18 A subxiphoid transthoracic epicardial puncture was 
performed using an epidural needle. As the needle was advanced, 
radiographic contrast was injected to confirm entry in the epicardial 
space, allowing the introduction of a J-tipped wire. Absence of 
needle entry in the right ventricle was demonstrated by advancing a 
guidewire along the left heart border in the left anterior oblique view 
and by aspirating amber pericardial fluid. A standard sheath then was 
advanced over the wire. A long and deflectable sheath was substituted 
and advanced into the transverse sinus of the pericardium as needed 
to improve catheter stability.6
Clinical Experience
In 2003 Schweikert et al. reported a series of previously failed 
catheter ablations in 48 patients who were subjected to combined 
epicardial–endocardial mapping. This series included 10 patients with 
AP-mediated tachycardia. In three of these cases, successful epicardial 
ablation of right atrial appendage–right ventricle epicardial APs was 
achieved. Of the other seven cases, epicardial mapping yielded earliest 
activation only in two cases, and ablation was ultimately successful 
from the endocardium but not from the epicardium.5
Cases of right atrial appendage–right ventricle AP have been 
described, although they represent rare situations (see Table 1).5,19–21 
Misidentification of the AP location is not uncommon and successful 
ablation may have to be performed far from the annulus, at the atrial 
appendage insertion site, which is the site of the earliest ventricular 
activation.18 However, the atrial appendage is a difficult target for 
ablation, even using irrigated catheters, due to limited blood flow 
between the catheter and the trabeculated surface of the appendage.20 
When endocardial ablation fails, a percutaneous epicardial approach 
has been demonstrated to be safe and effective in several case reports 
and can be considered an alternative to surgery.5
Left atrial appendage–left ventricle APs have recently been reported. 
Di Biase et al. described two adult patients with APs involving the 
left atrial appendage which were difficult to ablate with conventional 
catheter techniques.22 Mah et al. reported three paediatric patients 
in whom this AP was impossible to ablate percutaneously, ultimately 
requiring surgical intervention.23 Catheter ablation failure is likely due 
to the broad-based nature of the connection (requiring extensive 
surgical dissection) and the close proximity of the left atrial appendage 
to major coronary artery branches.23
In 2004, Valderábano et al. aimed to define the role of percutaneous 
epicardial mapping in six consecutive patients (with seven APs) 
referred for catheter ablation after previous attempts had failed. 
Endocardial and epicardial mapping were performed to identify 
optimal target sites for ablation. Whenever feasible, the endocardial 
catheter was positioned across from the epicardial catheter to 
compare electrograms. Epicardial RF delivery was performed only 
when electrograms showed that the APs were in the best epicardial 
sites and after endocardial RF delivery had failed. In this series, the 
most attractive target site for ablation was epicardial in three of the six 
patients, and an epicardial RF application was necessary for successful 
ablation in two of these patients.6
In 2015 we reviewed 21 patients referred for percutaneous epicardial 
AP ablation after a median of more than two previous procedures 
had failed.3 All patients underwent a simultaneous endocardial and 
epicardial approach. In six patients (28.5  %) epicardial activation 
was found earlier than endocardial activation and they underwent 
successful ablation from the epicardium. In three patients, simultaneous 
early activation at the epicardium and endocardium close to the mitral 
annulus was seen, and two of these patients were successfully 
ablated from the endocardium, guided by epicardial mapping. In nine 
patients endocardial activation was earlier than epicardial activation 
and in five of them subsequent endocardial or epicardial transvenous 
mapping and ablation resulted in AP elimination. Thus, subsequent 
endocardial or epicardial transvenous mapping and ablation resulted in 
AP elimination in seven patients (33 %). In three cases no early signals 
were found from endocardial or from epicardial activation.3
A percutaneous epicardial subxiphoid approach should be considered 
when endocardial (or transvenous) mapping fails to identify a suitable 
ablation target or if ablation from the best site is unsuccessful, as:
•  Epicardial mapping can find a true epicardial AP, where ablation is 
successful (see Figure 1A and B). When the AP is sub-epicardial, as 
Figure 1: Percutaneous Epicardial Ablation of a 
Posteroseptal Accessory Pathway
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(A) Left panel: CT lateral view of the heart. The yellow line represents the course of the 
ablation catheter in the pericardial space from its entrance (anterior approach) to the 
earliest ventricular activation site at the posteroseptal region. Middle panel: Fluoro image 
in left anterior oblique (LAO) view during right coronary artery angiography. Note the close 
relationship between the ablation catheter and the posterior descending branch. Right 
panel: Fluoro image in right anterior oblique (RAO) view during levo-phase contrasting of the 
middle cardiac vein (white arrowheads). The ablation catheter tip is in close contact with the 
MCV. The hatched yellow line depicts the level of the annulus. The ablation catheter tip is 
sitting 1.5 cm below the annulus. (B) The accessory pathway was ablated within 4 seconds 
of radiofrequency current delivery through the cool-tip ablation catheter (black star). CS os 
= coronary sinus ostium; EPI = epicardium; MCV = middle cardiac vein; RF = radiofrequency; 
STIM = stimulus; UNI = unipolar.
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is the case of right atrial appendage–right ventricular diverticulum, 
an epicardial (percutaneous or surgical) approach may be the only 
possibility.3 The percutaneous epicardial ablation success rate is only 
between 28 and 33 %, however, according to different series.3,5,6 One 
reason is the epicardial fat – which is thicker in the vicinity of the 
atrioventricular annulus, covering the region where AP sits – that 
hampers AP ablation.5 Proximity to a major coronary artery may be 
another obstacle precluding epicardial AP ablation, due to safety 
issues. Myocardial tissue and APs that are located underneath large 
epicardial arteries frequently remain intact after ablation.24
•  Epicardial mapping can guide and enhance the effectiveness 
of endocardial ablation. The identification of an early epicardial 
activation site works as a reference for successful endocardial 
ablation; patients with similar endocardium and epicardium 
activation times can successfully undergo endocardial ablation, 
according to data from the series previously presented.3 The 
epicardial approach allows easier and more complete mapping 
of the atrioventricular annulus without the anatomical restrictions 
of catheter manipulation from the endocardium. This approach 
also avoids distortion of epicardial electrograms from previous 
endocardial ablation attempts.6 
•  The finding of no early epicardial activation should lead to a more 
intensive and persistent endocardial attempt. In our series, five 
patients were successfully ablated after a further attempt at the 
endocardial approach (including the endocardium and coronary 
venous system) following epicardial mapping. We hypothesise 
that when pericardial mapping identifies no adequate target, the 
operator makes a greater effort as he or she realises that the 
endocardial approach is the only possibility of success.3 
•  When no epicardial or endocardial site with early activation is  
found to allow successful ablation, open-chest surgery is the only 
option to eliminate the AP, particularly for high-risk patients. It is 
important to be sure that no early activation is present during 
epicardial percutaneous mapping and to repeat endocardial 
mapping. An irrigated-tip ablation catheter should be used as it 
may improve results, especially in patients with coronary venous 
system-associated lesions. Congenital anatomical anomalies, 
such as CS diverticulum, venous stenosis and ostia atresia, are 
associated with a higher probability of requiring surgery.3 
Complications and Limitations
Although generally a safe procedure, subxiphoid percutaneous 
epicardial ablation of APs, like epicardial ablation of other arrhythmia 
substrates, may result in complications. Coronary injury is a matter of 
special concern. The procedure has the potential to damage epicardial 
vessels. This may occur while gaining access with the epidural needle, 
may be caused by the tip of the sheath or may occur during the 
delivery of epicardial radiofrequency current. Coronary angiography is 
the gold standard method for assessing the distance from the ablation 
site to a major coronary artery.5
Stavrakis et al.25 assessed 240 patients with an epicardial posteroseptal 
AP who had undergone ablation within the coronary venous system. 
The risk of coronary artery injury with radiofrequency ablation was 
inversely correlated with the distance between the coronary artery 
and the ablation site. Injury was observed in 50  %, 7  % and 0  % of 
patients when RF was performed within 2 mm, 3–5 mm and >5 mm of 
the coronary arteries. Cryoablation was found to be safe. No coronary 
lesions were reported, even when cryoablation was applied within 
5 mm of the coronary artery.
A potential advantage of the percutaneous epicardial approach 
is avoidance of the endovascular complications that might be 
encountered with conventional endocardial techniques, such 
as vascular injury, valve damage and embolism from coagulum or 
dislodged plaque during left-sided ablation procedures. Ventricular 
fibrillation was reported to have occurred after coronary vasospasm 
during catheter manipulation in one case and after severe pericardial 
bleeding caused by middle cardiac vein laceration in another 
patient.26 Another advantage is that the use of intravenous heparin, 
and its associated complications, could be avoided.5 A potential 
limitation of percutaneous pericardial instrumentation is that it 
should not be used in patients who have undergone prior cardiac 
surgery, as postoperative pericardial adhesions could limit access to 
the pericardial space.5
In our series,3 we did not have any major complications. In the two 
patients in whom the right ventricle was inadvertently punctured, 
pericardial haemorrhage was immediately recognised and drained, 
without any further complications. However, one must be aware 
that unusual complications may also occur, such as intra-abdominal 
bleeding due to puncture of the liver, hepatic haematoma, right 
ventricle–abdominal fistula, and right ventricular pseudoaneurysm.26 n
Clinical Perspective
•  A significant number of failed ablations with standard 
endocardial ablation methods might represent an epicardial 
arrhythmia substrate.
•  The epicardial substrate can be approached percutaneously 
through the cardiac venous system or through subxiphoid 
percutaneous epicardial access.
•  Percutaneous mapping in the pericardial space facilitates a 
successful outcome by improving the accuracy of endocardial 
mapping and subsequent endocardial ablation; percutaneous 
epicardial ablation has been successful in a minority of 
patients in whom this approach has been attempted.
•  Pericardial instrumentation is safe when performed by an 
experienced team.
•  A subset of patients may require open-chest surgery.
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